PRURITIS
Clinical trials for PRURITIS explained in plain language.
Never miss a new study
Get alerted when new PRURITIS trials appear
Sign up with your email to follow new studies for PRURITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for controlling chronic hives
Disease control CompletedThis study tested whether a new oral medication called povorcitinib could help adults with chronic spontaneous urticaria (CSU), a condition causing persistent hives and itching that doesn't respond well to standard antihistamines. Researchers compared different doses of the drug …
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New shot targets debilitating itch of skin condition
Symptom relief CompletedThis study tested whether an injectable drug called vixarelimab (KPL-716) could safely reduce severe itching and improve skin lesions in adults with prurigo nodularis. About 240 participants with moderate to severe symptoms received either the drug or a placebo for 8 to 16 weeks …
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC